EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.23.47 | Acquired Immunodeficiency Syndrome |
2668032 |
Inhibition of the aspartic proteinase from HIV-2. |
therapeutic application
unassigned |
1
0 |
| 3.4.23.47 | Acquired Immunodeficiency Syndrome |
8332607 |
A vector projection approach to predicting HIV protease cleavage sites in proteins. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.4.23.47 | Enzootic Bovine Leukosis |
1325379 |
Solid phase synthesis of the proteinase of bovine leukemia virus. Comparison of its specificity to that of HIV-2 proteinase. |
therapeutic application
unassigned |
1
0 |
| 3.4.23.47 | Infections |
18312292 |
Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.4.23.47 | Infections |
30593258 |
Characterizing the structural variability of HIV-2 protease upon the binding of diverse ligands using a structural alphabet approach. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 3.4.23.47 | Infections |
33503916 |
Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease. |
therapeutic application
unassigned |
1
0 |
